Evidence map›Paper›PMID 42360069›Full record

ArticleMicrobiology spectrum2026

Diagnostic performance and interchangeability of two commercial anti-RSV-IgG and IgA ELISAs across clinically relevant populations.

Rainer Gosert, Svenia Schmid, Laura Infanti, Andreas Holbro, Andreas Buser, Jakob Passweg, Jörg Halter, Jonas Lötscher, Carla S Walti, Sarah Tschudin-Sutter and 3 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rainer GosertClinical Virology, University Hospital Basel, Basel, Switzerland.
Svenia SchmidClinical Virology, University Hospital Basel, Basel, Switzerland.
Laura InfantiRegional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland.
Andreas HolbroRegional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland.
Andreas BuserRegional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland.ORCID 0000-0002-7942-6746
Jakob PasswegDivision of Hematology, University Hospital Basel, Basel, Switzerland.ORCID 0000-0001-7092-3351
Jörg HalterDivision of Hematology, University Hospital Basel, Basel, Switzerland.
Jonas LötscherDivision of Hematology, University Hospital Basel, Basel, Switzerland.
Carla S WaltiDivision of Infectious Diseases, University Hospital Basel, Basel, Switzerland.
Sarah Tschudin-SutterDivision of Infectious Diseases, University Hospital Basel, Basel, Switzerland.ORCID 0000-0003-4875-5368
Nina KhannaDivision of Infectious Diseases, University Hospital Basel, Basel, Switzerland.ORCID 0000-0002-2642-419X
Ulrich HeiningerDepartment of Paediatric Infectious Diseases and Vaccinology, University of Basel Children's Hospital, Basel, Switzerland.
Karoline LeuzingerClinical Virology, University Hospital Basel, Basel, Switzerland.ORCID 0000-0002-5654-9356

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate assessment of anti-respiratory syncytial virus (RSV)-specific antibodies has gained importance following the introduction of RSV vaccines and long-acting monoclonal antibody prophylaxis. However, the analytical performance and interchangeability of commercially available RSV-ELISAs remain insufficiently defined, leaving uncertainty about their reliability for clinical diagnostic practice. We performed a head-to-head comparison of the widely used commercial Euroimmun- and Virotech‒ELISA for detection of total anti-RSV‒IgG and IgA in 462 sera from four cohorts: healthy adults (

Indexed as

Antibodies, ViralImmunoglobulin AImmunoglobulin GRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsAdolescentAdultChildChild, PreschoolEnzyme-Linked Immunosorbent AssayFemaleHumansInfantMaleMiddle AgedPregnancyAntibodies, ViralImmunoglobulin AImmunoglobulin Ganti-RSV IgAanti-RSV IgGELISAprefusion F antibodiesrespiratory syncytial virusRSVserological surveillance

Identifiers

PMID42360069
PMCPMC13435726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.